Skip to content

Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder

Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05374616
Enrollment
300
Registered
2022-05-16
Start date
2018-05-18
Completion date
2030-01-01
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TANGO2-related Disorder

Brief summary

The study aims to establish a biorepository of individuals with TANGO2 deficiency to support scientific research and establish a comprehensive clinical database of affected individuals to understand the disease course.

Detailed description

TANGO2-related disorder is a rare autosomal recessive genetic disorder that can cause recurrent rhabdomyolysis and life-threatening cardiac arrhythmias. Metabolic crises can be triggered by prolonged fasting and dehydration. Intellectual disability, seizures, hypothyroidism, and gait abnormalities are observed frequently. The function of TANGO2 is unknown and the pathogenesis of this disease is poorly understood. Understanding disease mechanism requires studying disease cells/samples and thus establishing a biobank of tissues (blood and fibroblasts) of individuals affected with TANGO2 deficiency is paramount. Natural History Study of TANGO2-related disorder will allow investigators to understand the course of the disease and develop new therapies in the future to decrease morbidity associated with this genetic condition.

Interventions

GENETICObservation

Retrospective and prospective Natural History Study

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Days to No maximum
Healthy volunteers
No

Inclusion criteria

All patients with pathogenic TANGO2 variants will be included.

Exclusion criteria

Patients who do not have TANGO2-related disease will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with metabolic and cardiac crisis assessed by the number of hospitalizations10 yearsDetailed interview with participants and review of medical records will be used to assess the frequency and triggers of metabolic and cardiac crises

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026